APVOVSBIAF• 12 Months (Normalized)
APVO vs BIAF (Aptevo Therapeutics Inc. vs bioAffinity Technologies Inc.)
Showing Closing Date Range from Sep, 16, 2025 to Sep, 16, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
APVO Performance $1.72
-93.63%
Aptevo Therapeutics Inc.
Normalized Baseline0.00%
BIAF Performance $5.35
-95.44%
bioAffinity Technologies Inc.
Normalized Baseline0.00%
Alpha Spread Margin APVO LEADS
+1.81%
APVO outperforming by 1.81%
APVOBIAF
Spread Trajectory12 Months (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
APVO BIAF
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(252 dates)
| Date | APVO Price | APVO Gain (%) | BIAF Price | BIAF Gain (%) | Spread |
|---|---|---|---|---|---|
| Sep 16, 2026 | $1.72 | -93.63% | $5.35 | -95.44% | +1.81% |
| Sep 15, 2026 | $1.71 | -93.67% | $6.36 | -94.58% | +0.91% |
| Sep 14, 2026 | $1.80 | -93.33% | $7.93 | -93.25% | -0.08% |
| Sep 11, 2026 | $1.82 | -93.26% | $7.95 | -93.23% | -0.03% |
| Sep 10, 2026 | $1.83 | -93.22% | $9.39 | -92.01% | -1.21% |
| Sep 09, 2026 | $1.85 | -93.17% | $10.50 | -91.06% | -2.11% |
| Sep 08, 2026 | $1.88 | -93.04% | $8.93 | -92.40% | -0.64% |
| Sep 04, 2026 | $1.74 | -93.56% | $15.27 | -87.00% | -6.56% |
| Sep 03, 2026 | $1.71 | -93.67% | $12.78 | -89.12% | -4.55% |
| Sep 02, 2026 | $2.60 | -90.37% | $9.75 | -91.70% | +1.33% |
| Sep 01, 2026 | $2.34 | -91.33% | $6.59 | -94.39% | +3.06% |
| Aug 31, 2026 | $2.44 | -90.96% | $4.56 | -96.12% | +5.16% |
| Aug 28, 2026 | $2.37 | -91.24% | $4.87 | -95.85% | +4.61% |
| Aug 27, 2026 | $2.42 | -91.04% | $5.06 | -95.69% | +4.65% |
| Aug 26, 2026 | $2.41 | -91.07% | $5.09 | -95.67% | +4.60% |
Page 1 of 17